secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK:        0000879407
Form:       8-K
Filed at:   2022-07-20T23:59:59+00:00
Accession:  0001628280-22-019124
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Arrowhead appoints Patrick O'Brien as COO and General Counsel effective July 15, 2022
--------------------------------------------------------------------------------

- Patrick O'Brien (age 59) named Chief Operating Officer and General Counsel, effective July 15, 2022.
- He retains roles as Chief Compliance Officer and Corporate Secretary.
- O'Brien joined Arrowhead in December 2014 and previously served as General Counsel.
- Over 25 years healthcare legal experience, including positions at Shire, Johnson & Johnson, and the FDA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/879407/000162828022019124/0001628280-22-019124-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/879407/000162828022019124/arwr-20220715.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-019124

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer